P-114: Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览11
暂无评分
关键词
belantamab mafodotin therapy,relapsed/refractory multiple myeloma,multiple myeloma,real-world,multi-center
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要